Structures by: Liégeois J. F.
Total: 10
8-chloro-5-(4-methylpiperazin-1-yl)-11H-pyrido[2,3-b][1,5]benzoxazepine
C17H17ClN4O
Acta Crystallographica Section E (2003) 59, 12 o1962-o1963
a=8.5531(8)Å b=10.6765(8)Å c=17.2457(12)Å
α=90.00° β=93.347(10)° γ=90.00°
8-Chloro-6-(3-dimethylaminopropylamino)-11H-pyrido[2,3-b][1,4]benzodiazepine
C17H20ClN5
Acta Crystallographica Section E (2002) 58, 1 o69-o71
a=9.0010(10)Å b=20.421(3)Å c=9.9350(10)Å
α=90.00° β=109.545(6)° γ=90.00°
Cyproterone
C22H27ClO3
Acta Crystallographica Section E (2005) 61, 11 o3576-o3578
a=6.3880(10)Å b=14.182(2)Å c=21.107(3)Å
α=90° β=90° γ=90°
C17H19N5,1.5(H2O1)
C17H19N5,1.5(H2O1)
Acta Crystallographica Section C (1992) 48, 7 1322-1324
a=11.268(3)Å b=12.815(3)Å c=13.720(4)Å
α=107.370(10)° β=98.15(2)° γ=110.420(10)°
8-Chloro-5-(4-methylpiperazin-1-yl)-11H-pyrido[2,3-b][1,5]benzodiazepine
C17H18Cl1N5
Acta Crystallographica Section C (1996) 52, 2 391-393
a=11.9739(12)Å b=10.2088(11)Å c=14.662(2)Å
α=90.00° β=113.836(7)° γ=90.00°
3-methyl-6-(4-methylpiperazin-1-yl)-11H-pyrido[2,3-b][1,4]benzodiazepine
C18H21N5
Acta Crystallographica Section C (1995) 51, 9 1889-1891
a=9.3352(6)Å b=19.2342(10)Å c=9.3903(7)Å
α=90.00° β=93.039(6)° γ=90.00°
C18H18ClN3S
C18H18ClN3S
Acta Crystallographica Section C (1992) 48, 10 1851-1853
a=9.521(3)Å b=13.007(4)Å c=14.116(6)Å
α=90° β=100.770(10)° γ=90°
11-(4-methylpiperazin-1-yl)-5H-pyrido[4,3-b][1,5]benzodiazepine
C17H19N5
Acta Crystallographica Section C (1995) 51, 7 1379-1381
a=9.8098(5)Å b=16.5788(10)Å c=19.1759(8)Å
α=90.00° β=90.00° γ=90.00°
(+-)-2-Benzoyl-8-ethyl-1,2-dihydroisoquinoline-1-carbonitrile
C19H16N2O
Acta Crystallographica Section E (2007) 63, 7 o3161-o3161
a=7.9960(10)Å b=8.9480(10)Å c=11.297(2)Å
α=108.51(2)° β=94.860(10)° γ=93.040(10)°
C17H18ClN4O1,O.5(C4H4O4),0.5(C4H2O42)
C17H18ClN4O1,O.5(C4H4O4),0.5(C4H2O42)
Zeitschrift für Kristallographie - New Crystal Structures (2004) 219, 2 147-149
a=9.6247(11)Å b=9.929(3)Å c=11.860(2)Å
α=108.117(15)° β=73.237(10)° γ=87.380(10)°